Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct;62(10):1118-1119.
doi: 10.1111/dmcn.14626. Epub 2020 Jul 13.

Can anti-dopamine D2 receptor autoantibodies explain fluctuations of tic severity?

Affiliations
Free article
Comment

Can anti-dopamine D2 receptor autoantibodies explain fluctuations of tic severity?

Vasco A Conceição. Dev Med Child Neurol. 2020 Oct.
Free article
No abstract available

PubMed Disclaimer

Comment on

  • Anti-dopamine D2 receptor antibodies in chronic tic disorders.
    Addabbo F, Baglioni V, Schrag A, Schwarz MJ, Dietrich A, Hoekstra PJ, Martino D, Buttiglione M; Emtics Collaborative Group. Addabbo F, et al. Dev Med Child Neurol. 2020 Oct;62(10):1205-1212. doi: 10.1111/dmcn.14613. Epub 2020 Jul 9. Dev Med Child Neurol. 2020. PMID: 32644201

References

    1. Maia TV, Conceição VA. The roles of phasic and tonic dopamine in tic learning and expression. Biol Psychiatry 2017; 82: 401-12.
    1. Maia TV, Conceição VA. Dopaminergic disturbances in Tourette syndrome: an integrative account. Biol Psychiatry 2018; 84: 332-44.
    1. Addabbo F, Baglioni V, Schrag A, et al. Anti-dopamine D2 receptor antibodies in chronic tic disorders: potential link to fluctuations of tic severity. Dev Med Child Neurol 2020. https://doi.org/10.1111/dmcn.14613
    1. Pollak TA, Beck K, Irani SR, et al. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology (Berl) 2016; 233: 1605-21.
    1. Sinmaz N, Tea F, Pilli D, et al. Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders. Acta Neuropathol Commun 2016; 4: 126.

LinkOut - more resources